Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Ubiquitin B anticorps (AA 103-228)

UBB Reactivité: Humain ELISA, IHC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7163895
  • Antigène Voir toutes Ubiquitin B (UBB) Anticorps
    Ubiquitin B (UBB)
    Épitope
    • 6
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 103-228
    Reactivité
    • 48
    • 25
    • 19
    • 13
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 42
    • 16
    Lapin
    Clonalité
    • 36
    • 22
    Polyclonal
    Conjugué
    • 31
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp Ubiquitin B est non-conjugé
    Application
    • 38
    • 19
    • 19
    • 15
    • 10
    • 9
    • 6
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    ELISA, Immunohistochemistry (IHC)
     Réactivité croisée
    Humain
    Purification
    >95%, Antigen Affinity purified & Affinity purified
    Immunogène
    Recombinant Human Polyubiquitin-B protein (103-228AA)
    Isotype
    IgG
    Top Product
    Discover our top product UBB Anticorps primaire
  • Indications d'application
    Recommended dilution: IHC:1:20-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    Ubiquitin B (UBB)
    Autre désignation
    UBB (UBB Produits)
    Synonymes
    anticorps AL033289, anticorps Rps27a, anticorps Uba52, anticorps Ubb2, anticorps Ubc, anticorps UBC, anticorps Ubiquitin, anticorps UBB, anticorps Ubi-p63E, anticorps im:6892314, anticorps si:ch211-202a12.3, anticorps ubc, anticorps zUBC, anticorps zgc:172187, anticorps ubiquitin B, anticorps ubiquitin C, anticorps UBB, anticorps Ubb, anticorps UBC, anticorps ubb
    Sujet

    Background: Ubiquitin: Exists either covalently attached to another protein, or free (unanchored). When covalently bound, it is conjugated to target proteins via an isopeptide bond either as a monomer (monoubiquitin), a polymer linked via different Lys residues of the ubiquitin (polyubiquitin chains) or a linear polymer linked via the initiator Met of the ubiquitin (linear polyubiquitin chains). Polyubiquitin chains, when attached to a target protein, have different functions depending on the Lys residue of the ubiquitin that is linked: Lys-6-linked may be involved in DNA repair, Lys-11-linked is involved in ERAD (endoplasmic reticulum-associated degradation) and in cell-cycle regulation, Lys-29-linked is involved in lysosomal degradation, Lys-33-linked is involved in kinase modification, Lys-48-linked is involved in protein degradation via the proteasome, Lys-63-linked is involved in endocytosis, DNA-damage responses as well as in signaling processes leading to activation of the transcription factor NF-kappa-B. Linear polymer chains formed via attachment by the initiator Met lead to cell signaling. Ubiquitin is usually conjugated to Lys residues of target proteins, however, in rare cases, conjugation to Cys or Ser residues has been observed. When polyubiquitin is free (unanchored-polyubiquitin), it also has distinct roles, such as in activation of protein kinases, and in signaling.

    Aliases: UBB antibody, UBB_HUMAN antibody, Ubiquitin antibody

    UniProt
    P0CG47
    Pathways
    Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Activation of Innate immune Response, Mitotic G1-G1/S Phases, DNA Replication, Toll-Like Receptors Cascades, Synthesis of DNA, Autophagy, EGFR Downregulation, Ubiquitin Proteasome Pathway
Vous êtes ici: